Mar 2, 2026 09:45AM
Feb 27, 2026 06:35AM
Jan 27, 2026 05:18PM
Jan 9, 2026 11:00AM
Dec 23, 2025 01:29PM
Dec 22, 2025 04:01PM
Dec 5, 2025 08:02AM Amneal reports positive interim results for Parkinson's drug CREXONT
Oct 30, 2025 06:04AM
Oct 29, 2025 04:09PM
Sep 26, 2025 08:02AM
Sep 22, 2025 03:15PM
Aug 5, 2025 06:10AM
Jul 21, 2025 07:40AM
Jun 25, 2025 08:04AM Amneal Pharmaceuticals (AMRX) Highlights Positive Topline Results from Confirmatory Clinical Study of Biosimilar Candidate to XOLAIR
Jun 12, 2025 08:01AM
Jun 6, 2025 03:30AM
May 21, 2025 07:22AM
May 15, 2025 08:00AM
May 12, 2025 11:36AM
May 2, 2025 06:03AM
Apr 23, 2025 03:44PM Amneal Pharmaceuticals (AMRX) Recalls Ropivacaine Hydrochloride Injection
Apr 7, 2025 08:00AM
Apr 3, 2025 08:01AM
Mar 3, 2025 04:10PM
Feb 28, 2025 06:06AM
Feb 24, 2025 01:04AM
Feb 19, 2025 08:00AM
Jan 23, 2025 08:01AM Amneal Pharmaceuticals (AMRX) Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin
Nov 21, 2024 04:07PM
Nov 11, 2024 07:22AM
Nov 8, 2024 06:02AM
Oct 21, 2024 08:01AM
Oct 2, 2024 06:37AM
Oct 1, 2024 03:02PM
Oct 1, 2024 01:42PM Truist Securities Reiterates Buy Rating on Amneal Pharmaceuticals (AMRX)
Sep 23, 2024 08:13AM
Sep 6, 2024 03:40AM
Sep 5, 2024 04:06PM
Aug 20, 2024 08:01AM
Aug 9, 2024 06:07AM
Jul 29, 2024 04:05PM
Jul 9, 2024 04:05PM Amneal Pharmaceuticals (AMRX) Launches FOCINVEZ

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All